[Multiple cranial neuropathy: a case report of three paediatric patients].

Autor: Sancho-Montero N; Hospital Universitario Reina Sofia, 14004 Cordoba, Espana., Fernandez-Ramos JA; Hospital Universitario Reina Sofia, Cordoba, Espana., Caballero-Rodriguez C; Hospital Universitario Reina Sofia, 14004 Cordoba, Espana., Camino-Leon R; Hospital Universitario Reina Sofia, 14004 Cordoba, Espana., Lopez-Laso E; Hospital Universitario Reina Sofia, 14004 Cordoba, Espana.

Publikováno v: Revista de neurologia [Rev Neurol] 2018 Oct 16; Vol. 67 (8), pp. 321-323.

Urinary sulphatoxymelatonin as a biomarker of serotonin status in biogenic amine-deficient patients.

Autor: Batllori M; Clinical Biochemistry and Neuropediatric Departments, Institut de Recerca Sant Joan de Déu (IRSJD), Hospital Sant Joan de Déu, Esplugues de Llobregat, Spain., Molero-Luis M; Clinical Biochemistry and Neuropediatric Departments, Institut de Recerca Sant Joan de Déu (IRSJD), Hospital Sant Joan de Déu, Esplugues de Llobregat, Spain.; Centre for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain., Arrabal L; Neuropediatric Department, Complejo Hospitalario Universitario de Granada, Granada, Spain., Heras JL; Division of Pediatric Metabolism, Hospital Universitario de Cruces, Barakaldo and University of the Basque Country UPV/EHU, Vizcaya, Spain., Fernandez-Ramos JA; Pediatric Neurology Unit, Departament of Pediatrics, Reina Sofia University Hospital, Cordoba, Spain., Gutiérrez-Solana LG; Neuropediatric Department, Hospital Infantil Universitario Niño Jesús, Madrid, Spain., Ibáñez-Micó S; Neuropediatric Department, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain., Domingo R; Neuropediatric Department, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain., Campistol J; Clinical Biochemistry and Neuropediatric Departments, Institut de Recerca Sant Joan de Déu (IRSJD), Hospital Sant Joan de Déu, Esplugues de Llobregat, Spain.; Centre for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain., Ormazabal A; Clinical Biochemistry and Neuropediatric Departments, Institut de Recerca Sant Joan de Déu (IRSJD), Hospital Sant Joan de Déu, Esplugues de Llobregat, Spain.; Centre for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain., Sedel F; MedDay Pharmaceuticals, ICM-Brain and Spine Institute-IPEPs, Groupe Hospitalier Pitié Salpêtrière, 47 Boulevard de l'Hopital, 75013, Paris, France., Opladen T; Department of Child Neurology and Metabolic Disorders, University Children's Hospital, Heidelberg, Germany., Zouvelou B; Agia Sofia Hospital, Special Pediatric Neurology Unit, First Department of Pediatrics, National and Kapodistrian University of Athens, Athens, Greece., Pons R; Agia Sofia Hospital, Special Pediatric Neurology Unit, First Department of Pediatrics, National and Kapodistrian University of Athens, Athens, Greece., Garcia-Cazorla A; Clinical Biochemistry and Neuropediatric Departments, Institut de Recerca Sant Joan de Déu (IRSJD), Hospital Sant Joan de Déu, Esplugues de Llobregat, Spain.; Centre for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain., Lopez-Laso E; Centre for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.; Pediatric Neurology Unit, Department of Pediatrics, Reina Sofia University Hospital, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Cordoba, Spain., Artuch R; Clinical Biochemistry and Neuropediatric Departments, Institut de Recerca Sant Joan de Déu (IRSJD), Hospital Sant Joan de Déu, Esplugues de Llobregat, Spain. rartuch@hsjdbcn.org.; Centre for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain. rartuch@hsjdbcn.org.

Publikováno v: Scientific reports [Sci Rep] 2017 Nov 07; Vol. 7 (1), pp. 14675. Date of Electronic Publication: 2017 Nov 07.